Borg, Rikke <br/><br/>
Empagliflozin reduces albuminuria-a promise for better cardiorenal protection from the EMPA-REG OUTCOME trial.  [electronic resource] 

 -  Annals of translational medicine  Dec 2017 
 - 478 p.  digital 
<br/><br/> Publication Type: Editorial; Comment 
<br/><br/><label>ISSN: </label>2305-5839 
<br/><br/><label>Standard No.: </label>10.21037/atm.2017.11.02  doi